Trial intelligence / Profile preview

Alpha-Lipoic Acid for Endothelial Function in Type 2 Diabetes

NCT00490867Phase 2Completed

Sponsor
Medical University of Vienna
Start
Jul 2004
Modality
Small Molecules
01

Overview

A Phase 2 trial of alpha-lipoic acid in type 2 diabetes mellitus (T2DM), sponsored by Medical University of Vienna. Started Jul 2004; status: completed.

02

Drugs

alpha-lipoic acid
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00490867.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00490867.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call